Provided by Dayle Kern, American Academy of Ophthalmology Research shows that, of 11 popular supplements analyzed, 7 do not adhere to proven formulas; all 11 have misleading claims With Americans spending billions of dollars each year on...
Latest AMD Stories
Fourth Quarter Milestone Achievements Increase Customer Base, Spur Sales and Marketing Expansion SARATOGA, Calif., Dec.
DALLAS, December 15, 2014 /PRNewswire/ -- ReportsnReports.com adds Ocular Disorders: Rising Therapeutics, Technologies, and Devices 2014 market research report that covers
Research shows that, of 11 popular supplements analyzed, 7 do not adhere to proven formulas; all 11 have misleading claims SAN FRANCISCO, Dec.
Conference Call Scheduled for Wednesday, December 3rd to Provide Investor Update SAN DIEGO, Dec. 2, 2014 /PRNewswire/ -- Lpath, Inc.
LOUISVILLE, Ky., Dec.
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
National research foundation will host FREE seminars in Naples and Palm Beach Gardens on age-related macular degeneration to provide information on the latest research, treatment and technology for
CRESTWOOD, Ky., Nov. 20, 2014 /PRNewswire/ -- Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.
BOCA RATON, Fla., Nov.
Novel Therapies Demonstrating Evidence of Superior Head-to-Head Efficacy Will Expand the Role of Adjunct Therapy, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.
- A transitional zone between two communities containing the characteristic species of each.